183 related articles for article (PubMed ID: 33894110)
1. Revisiting the effect of GnRH analogue treatment on bone mineral density in young adolescents with gender dysphoria.
Biggs M
J Pediatr Endocrinol Metab; 2021 Jul; 34(7):937-939. PubMed ID: 33894110
[No Abstract] [Full Text] [Related]
2. Bone Development in Transgender Adolescents Treated With GnRH Analogues and Subsequent Gender-Affirming Hormones.
Schagen SEE; Wouters FM; Cohen-Kettenis PT; Gooren LJ; Hannema SE
J Clin Endocrinol Metab; 2020 Dec; 105(12):e4252-63. PubMed ID: 32909025
[TBL] [Abstract][Full Text] [Related]
3. Physical changes, laboratory parameters, and bone mineral density during testosterone treatment in adolescents with gender dysphoria.
Stoffers IE; de Vries MC; Hannema SE
J Sex Med; 2019 Sep; 16(9):1459-1468. PubMed ID: 31405768
[TBL] [Abstract][Full Text] [Related]
4. The effect of GnRH analogue treatment on bone mineral density in young adolescents with gender dysphoria: findings from a large national cohort.
Joseph T; Ting J; Butler G
J Pediatr Endocrinol Metab; 2019 Oct; 32(10):1077-1081. PubMed ID: 31472062
[TBL] [Abstract][Full Text] [Related]
5. Children and adolescents in the Amsterdam Cohort of Gender Dysphoria: trends in diagnostic- and treatment trajectories during the first 20 years of the Dutch Protocol.
van der Loos MATC; Klink DT; Hannema SE; Bruinsma S; Steensma TD; Kreukels BPC; Cohen-Kettenis PT; de Vries ALC; den Heijer M; Wiepjes CM
J Sex Med; 2023 Feb; 20(3):398-409. PubMed ID: 36763938
[TBL] [Abstract][Full Text] [Related]
6. Blood Pressure Dynamics After Pubertal Suppression with Gonadotropin-Releasing Hormone Analogs Followed by Testosterone Treatment in Transgender Male Adolescents: A Pilot Study.
Perl L; Segev-Becker A; Israeli G; Elkon-Tamir E; Oren A
LGBT Health; 2020; 7(6):340-344. PubMed ID: 32735503
[No Abstract] [Full Text] [Related]
7. Effect of pubertal suppression and cross-sex hormone therapy on bone turnover markers and bone mineral apparent density (BMAD) in transgender adolescents.
Vlot MC; Klink DT; den Heijer M; Blankenstein MA; Rotteveel J; Heijboer AC
Bone; 2017 Feb; 95():11-19. PubMed ID: 27845262
[TBL] [Abstract][Full Text] [Related]
8. Bone Mineral Density in Transgender Adolescents Treated With Puberty Suppression and Subsequent Gender-Affirming Hormones.
van der Loos MATC; Vlot MC; Klink DT; Hannema SE; den Heijer M; Wiepjes CM
JAMA Pediatr; 2023 Dec; 177(12):1332-1341. PubMed ID: 37902760
[TBL] [Abstract][Full Text] [Related]
9. Transition memories: experiences of trans adult women with hormone therapy and their beliefs on the usage of hormone blockers to suppress puberty.
Giovanardi G; Morales P; Mirabella M; Fortunato A; Chianura L; Speranza AM; Lingiardi V
J Endocrinol Invest; 2019 Oct; 42(10):1231-1240. PubMed ID: 30953318
[TBL] [Abstract][Full Text] [Related]
10. Short-term outcomes of pubertal suppression in a selected cohort of 12 to 15 year old young people with persistent gender dysphoria in the UK.
Carmichael P; Butler G; Masic U; Cole TJ; De Stavola BL; Davidson S; Skageberg EM; Khadr S; Viner RM
PLoS One; 2021; 16(2):e0243894. PubMed ID: 33529227
[TBL] [Abstract][Full Text] [Related]
11. Pubertal Suppression, Bone Mass, and Body Composition in Youth With Gender Dysphoria.
Navabi B; Tang K; Khatchadourian K; Lawson ML
Pediatrics; 2021 Oct; 148(4):. PubMed ID: 34497118
[TBL] [Abstract][Full Text] [Related]
12. Transgender and Gender Nonconforming Youth.
Forcier M; Olson J
Adolesc Med State Art Rev; 2014 Aug; 25(2):377-97. PubMed ID: 27132320
[No Abstract] [Full Text] [Related]
13. Trajectories of Adolescents Treated with Gonadotropin-Releasing Hormone Analogues for Gender Dysphoria.
Brik T; Vrouenraets LJJJ; de Vries MC; Hannema SE
Arch Sex Behav; 2020 Oct; 49(7):2611-2618. PubMed ID: 32152785
[TBL] [Abstract][Full Text] [Related]
14. A systematic review of hormone treatment for children with gender dysphoria and recommendations for research.
Ludvigsson JF; Adolfsson J; Höistad M; Rydelius PA; Kriström B; Landén M
Acta Paediatr; 2023 Nov; 112(11):2279-2292. PubMed ID: 37069492
[TBL] [Abstract][Full Text] [Related]
15. Urological and Gynaecological Considerations for the Use of Gonadotropin-releasing Hormone Analogues in Transgender and Nonbinary Adolescents: A Narrative Review.
Lee WG; Butler G; Carmichael P; Rashid T; Yasmin E; Morley R; Barrett J; Christopher N; Sangster P
Eur Urol Focus; 2023 Jan; 9(1):35-41. PubMed ID: 36396559
[TBL] [Abstract][Full Text] [Related]
16. Blood pressure dynamics after pubertal suppression with gonadotropin-releasing hormone analogs followed by estradiol treatment in transgender female adolescents: a pilot study.
Perl L; Elkon-Tamir E; Segev-Becker A; Israeli G; Brener A; Oren A
J Pediatr Endocrinol Metab; 2021 Jun; 34(6):741-745. PubMed ID: 33823098
[TBL] [Abstract][Full Text] [Related]
17. Development of Hip Bone Geometry During Gender-Affirming Hormone Therapy in Transgender Adolescents Resembles That of the Experienced Gender When Pubertal Suspension Is Started in Early Puberty.
van der Loos MA; Hellinga I; Vlot MC; Klink DT; den Heijer M; Wiepjes CM
J Bone Miner Res; 2021 May; 36(5):931-941. PubMed ID: 33507568
[TBL] [Abstract][Full Text] [Related]
18. Gender dysphoria in children and adolescents: an overview.
Skordis N; Kyriakou A; Dror S; Mushailov A; Nicolaides NC
Hormones (Athens); 2020 Sep; 19(3):267-276. PubMed ID: 32020566
[TBL] [Abstract][Full Text] [Related]
19. Systematic Review: Puberty suppression with GnRH analogues in adolescents with gender incongruity.
Ramos GGF; Mengai ACS; Daltro CAT; Cutrim PT; Zlotnik E; Beck APA
J Endocrinol Invest; 2021 Jun; 44(6):1151-1158. PubMed ID: 33111215
[TBL] [Abstract][Full Text] [Related]
20. Transgender medicine- transitioning transgender children to adulthood.
Abramowitz J
Rev Endocr Metab Disord; 2018 Sep; 19(3):227-230. PubMed ID: 30123939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
